Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease
Clinical trial NCT02545049 · COMPLETED
Trial details
- NCT number
- NCT02545049
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-17
- Primary completion
- 2021-02-02
- Enrollment
- 7352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.